Systems and methods for processing electronic images for computational assessment of disease

1. A computer-implemented method for processing electronic images, the method comprising:

receiving a digital image corresponding to a target specimen collected using a histopathology technique, wherein the digital image is an image of tissue specimen;

determining a detection machine learning model, the detection machine learning model being generated by processing a plurality of training images to output a cancer qualification and further output a cancer quantification if the cancer qualification is an confirmed cancer qualification;

providing the digital image as an input to the detection machine learning model;

receiving a pathological complete response (pCR) cancer qualification when the output of the detection machine learning model comprises a pCR cancer qualification and receiving a confirmed cancer quantification comprising one of a number of cancer cells or a density of cancer cells when the output of the detection machine learning model comprises a confirmed cancer quantification, and wherein receiving the confirmed cancer quantification also comprises receiving a type of cancer when the output of the detection machine learning model comprises a confirmed cancer quantification, wherein the type of cancer is determined based on the digital image and one or more of a tissue characteristics, slide type, glass type, tissue type, tissue region, chemical used, or stain amount, wherein the detection machine learning model comprises a treatment effect machine learning model, and wherein the treatment effect machine learning model is initialized with one of weights and/or layers from a trained version of the detection machine learning model and the treatment effect machine learning model is trained based on tagged treatment effects in the plurality of training images; and

outputting the pCR cancer qualification or the confirmed cancer quantification based on the treatment effects machine learning model.

2. The computer-implemented method of claim 1 , wherein receiving the confirmed cancer quantification comprises receiving a minimal residual disease (MRD) cancer quantification.

3. The computer-implemented method of claim 2 , wherein the MRD cancer quantification is protocol specific.

4. The computer-implemented method of claim 2 , wherein the MRD cancer quantification corresponds to a number of cancer cells below a MRD threshold.

5. The computer-implemented method of claim 1 , wherein the pCR cancer qualification corresponds to the digital image having zero detectable cancer cells.

6. The computer-implemented method of claim 1 , wherein the plurality of training images comprise images with treatment effects.

7. A system for processing electronic images, the system comprising:

at least one memory storing instructions; and

at least one processor executing the instructions to perform operations comprising:

receiving a digital image corresponding to a target specimen collected using a histopathology technique, wherein the digital image is an image of tissue specimen;

determining a detection machine learning model, the detection machine learning model being generated by processing a plurality of training images to output a cancer qualification and further output a cancer quantification if the cancer qualification is a confirmed cancer qualification;

receiving tagged treatment effects in the plurality of training images;

providing the digital image as an input to the detection machine learning model wherein the processor is configured to receive a pathological complete response (pCR) cancer qualification when the output of the detection machine learning model comprises the pCR cancer qualification and also configured to receive a confirmed cancer quantification comprising one of a number of cancer cells or a density of cancer cells when the output of the detection machine learning model comprises the confirmed cancer quantification, and wherein receiving the confirmed cancer quantification also comprises receiving a type of cancer when the output of the detection machine learning model comprises a confirmed cancer quantification, wherein the type of cancer is determined based on the digital image and one or more of a tissue characteristics, slide type, glass type, tissue type, tissue region, chemical used, or stain amount;

receiving the pCR cancer qualification when the output of the detection machine learning model comprises the pCR qualification and receiving the confirmed cancer qualification when the output of the detection machine learning model comprises the confirmed cancer qualification, wherein the detection machine learning model comprises a treatment effect machine learning model, and wherein the treatment effect machine learning model is initialized with one of weights or layers from a trained version of the detection machine learning model and the treatment effect machine learning model is trained based on tagged treatment effects in the plurality of training images; and

outputting the pCR cancer qualification or the confirmed cancer quantification based on the treatment effects machine learning model.

8. The system of claim 7 , wherein receiving the confirmed cancer qualification further comprises receiving a minimal residual disease (MRD) cancer quantification.

9. The system of claim 8 , wherein the MRD cancer qualification is protocol specific.

10. The system of claim 7 , wherein the confirmed cancer qualification corresponds to detecting a threshold number of cancer cells.

11. The system of claim 7 , wherein the plurality of training images comprise images with treatment effects.

12. The system of claim 7 , wherein the detection machine learning model comprises a treatment effect machine learning model.

13. A non-transitory computer-readable medium storing instructions that, when executed by processor, cause the processor to perform operations for processing electronic images, the operations comprising:

receiving a digital image corresponding to a target specimen collected using a histopathology technique, wherein the digital image is an image of tissue specimen;

determining a detection machine learning model, the detection machine learning model being generated by processing a plurality of training images to output a cancer qualification and further output a cancer quantification if the cancer qualification is a confirmed cancer qualification;

providing the digital image as an input to the detection machine learning model wherein the processor is configured to receive a pathological complete response (pCR) cancer qualification when the output of the detection machine learning model comprises a pCR cancer qualification and also configured to receive a confirmed cancer quantification when the output of the detection machine learning model comprises a confirmed cancer quantification;

receiving the pCR cancer qualification when the output of the detection machine learning model comprises the pCR qualification and receiving the confirmed cancer qualification comprising one of a number of cancer cells or a density of cancer cells when the output of the detection machine learning model comprises the confirmed cancer qualification, and wherein receiving the confirmed cancer quantification also comprises receiving a type of cancer when the output of the detection machine learning model comprises a confirmed cancer quantification, wherein the type of cancer is determined based on the digital image and one or more of a tissue characteristics, slide type, glass type, tissue type, tissue region, chemical used, or stain amount, wherein the detection machine learning model comprises a treatment effect machine learning model, and wherein the treatment effect machine learning model is initialized with one of weights and/or layers from a trained version of the detection machine learning model and the treatment effect machine learning model is trained based on tagged treatment effects in the plurality of training images; and

outputting the pCR cancer qualification or the confirmed cancer quantification based on the treatment effects machine learning model.

14. The non-transitory computer-readable medium of claim 13 , wherein receiving the confirmed cancer quantification comprises receiving a minimal residual disease (MRD) cancer quantification.

15. The non-transitory computer-readable medium of claim 13 , wherein the detection machine learning model comprises a treatment effect machine learning model.